Riskpilot← Back to searchSign inGet full accessDKA konsult AB
ABActiveOrg 5590985023Holmvägen 38General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2024
SEK 3M
+37% vs 2023
EBITDA margin
3.2%
+309% vs 2023
Equity ratio
85.5%
Financial strength
Net profit 2024
SEK 95K
+330% vs 2023
| Revenue | SEK 3M | +37% |
| EBITDA | SEK 95K | +309% |
| Net profit | SEK 95K | +330% |
| Total assets | SEK 1,8M | -14% |
| Equity | SEK 1,6M | +6% |
| Employees | 0 | — |
Legal name
DKA konsult AB
Org number
5590985023
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
26 januari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom läkaryrket i sjukvården såväl inom privat såsom offentlig sektor och därmed förenlig verksamhet. Bolaget ska även bedriva fordonshandel, värdepappershandel samt handel och förvaltning av fastigheter.
Address
Holmvägen 38
Email
emir@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 351 | 3 464 | 2 175 | 2 974 |
| Staff expenses | — | — | −1 | −3 | −2 |
| EBITDA | −3 | 4 | 56 | −46 | 95 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −3 | 4 | 56 | −46 | 95 |
| Net financials | — | — | 0 | 4 | 12 |
| Profit before tax | −3 | 4 | 56 | −41 | 107 |
| Tax | −0 | −0 | −12 | — | −13 |
| Net profit | −3 | 4 | 45 | −41 | 95 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 531 | 1 466 | 2 144 | 2 125 | 1 826 |
| Equity | 1 459 | 1 463 | 1 507 | 1 466 | 1 561 |
| Long-term debt | 0 | 0 | 625 | 625 | 125 |
| Short-term debt | 72 | 4 | 12 | 34 | 140 |
| Total debt | 72 | 4 | 637 | 659 | 265 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
85.5%
This company
38.2%
Market median
+124% vs market
20202024
Return on equity
6.1%
This company
18.4%
Market median
-67% vs market
20202024
Net profit margin
3.2%
This company
8.1%
Market median
-60% vs market
20202024
Asset turnover
1.63×
This company
1.12×
Market median
+46% vs market
20202024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EK Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DKA konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emir Kalajdzic | Chief Executive Officer | 0 companies |
| Meliha Kalajdzic | Chairman | 0 companies |
| Dzemil Kalajdzic | Board of Directors | 0 companies |
| Irfan Kalajdzic | Deputy Board Member | 0 companies |